Miconazole%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520vaginal%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520pessary

# Miconazole Vaginal Pessary ## Overview Miconazole is an imidazole antifungal agent that inhibits the synthesis of ergosterol, a component of fungal cell membranes. ## Primary Indications Treatment of vulvovaginal candidiasis (yeast infection). ## Adult Dosing * **100 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 7 consecutive days. * **200 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 3 consecutive days. * **100 mg vaginal suppository:** Insert 1 suppository vaginally at bedtime for 7 consecutive days. * **200 mg vaginal suppository:** Insert 1 suppository vaginally at bedtime for 3 consecutive days. *Note: The term "pessary" and "suppository" are often used interchangeably in this context.* ## Pediatric Dosing * Data on the safety and efficacy of miconazole vaginal pessaries in pediatric patients are limited. Use with caution and consider alternative treatments if available. Consult specific pediatric guidelines if necessary. ## Dose Adjustments No dose adjustments are typically required for renal or hepatic impairment when used as a vaginal pessary. ## Contraindications * Hypersensitivity to miconazole or any component of the formulation. * Concomitant use with certain CYP3A4 substrates (e.g., cisapride, pimozide, quinidine, triazolam, certain statins). ## Adverse Effects * **Common:** Vaginal burning, itching, irritation, lower abdominal cramping. * **Less Common:** Headache, rash, vulvar swelling. ## Key Drug Interactions * **CYP3A4 Inhibitors:** Miconazole is a potent inhibitor of CYP3A4. Co-administration with drugs metabolized by CYP3A4 can lead to increased plasma concentrations and potential toxicity. Avoid co-administration with cisapride, pimozide, quinidine, and certain statins (simvastatin, lovastatin). Use caution with other CYP3A4 substrates. * **Warfarin:** Miconazole may increase the anticoagulant effect of warfarin. Monitor INR closely and consider dose adjustments. ## Monitoring * Monitor for signs and symptoms of vulvovaginal candidiasis. * Assess for adverse effects. * If using concurrently with warfarin, monitor INR. ## Clinical Pearls * Complete the full course of treatment, even if symptoms improve earlier. * Avoid sexual intercourse during treatment to prevent potential irritation and reduced efficacy. * The oil-based vehicle may weaken latex condoms and diaphragms, leading to failure. Advise patients to use alternative birth control methods during treatment and for at least 72 hours after completion. * If symptoms do not improve after completing the course, or if they worsen, re-evaluate the diagnosis and consider alternative antifungal therapy. *** **Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and institutional protocols before making any clinical decisions. Dosing and recommendations may vary based on individual patient factors and local guidelines.